Drug Metabolism Letters
Title:Meet Our Editorial Board Member:
Volume: 10 Issue: 3
Author(s): M. Kajbaf
Affiliation:
Export Options
About this article
Cite this article as:
Kajbaf M., Meet Our Editorial Board Member:, Drug Metabolism Letters 2016; 10 (3) . https://dx.doi.org/10.2174/187231281003160929160728
DOI https://dx.doi.org/10.2174/187231281003160929160728 |
Print ISSN 1872-3128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-0758 |
25
Related Articles
-
Editorial (Hot Topic: Anti-Inflammatory Drugs and the Heart Special Thematic)
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Natriuretic Peptide Testing in Primary Care
Current Cardiology Reviews An Update to Enterococcal Bacteremia: Epidemiology, Resistance, and Outcome
Infectious Disorders - Drug Targets A Review of Probiotic Supplementation and Feasibility of Topical Application for the Treatment of Pediatric Atopic Dermatitis
Current Pharmaceutical Biotechnology Recent Patents on Oil Analysis Technologies of Mechanical Equipment
Recent Patents on Mechanical Engineering Differential Expression of Genes in Obesity and Type 2 Diabetes Mellitus
Current Nutrition & Food Science The Role of the Thrombospondins in Healing Myocardial Infarcts
Cardiovascular & Hematological Agents in Medicinal Chemistry The 100 Most-Cited Papers on Giant Cell Arteritis: A Bibliometric Analysis
Current Rheumatology Reviews Adult Stem Cells and the Clinical Arena: Are we Able to Widely Use this Therapy in Patients with Chronic Limbs Arteriopathy and Ischemic Ulcers without Possibility of Revascularization?
Cardiovascular & Hematological Agents in Medicinal Chemistry Medicinal Perspective of Indole Derivatives: Recent Developments and Structure-Activity Relationship Studies
Current Drug Targets ACKNOWLEDGEMENT
Recent Patents on Cardiovascular Drug Discovery Liraglutide-A Novel GLP-1 Analogue
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect
Endocrine, Metabolic & Immune Disorders - Drug Targets Fingolimod (FTY720) Reduces Cortical Infarction and Neurological Deficits During Ischemic Stroke Through Potential Maintenance of Microvascular Patency
Current Neurovascular Research Concomitant Gene Mutations of MBL and CYBB in Chronic Granulomatous Disease: Implications for Host Defense
Inflammation & Allergy - Drug Targets (Discontinued) Stem Cell Therapy in Chronic Ischemic Heart Dysfunction with and Without Viability
Cardiovascular & Hematological Disorders-Drug Targets ENaC in the Brain - Future Perspectives and Pharmacological Implications
Current Molecular Pharmacology Growth and Differentiation of Human Embryonic Stem Cells for Cardiac Cell Replacement Therapy
Current Stem Cell Research & Therapy Retraction Notice: Assessment of the Spatial QRS-T Angle by Vectorcardiography: Current Data and Perspectives
Current Cardiology Reviews Editorial [PET and SPECT in Drug Evaluation and Drug Design: Novel Techniques]
Current Pharmaceutical Design